- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
AON Issues Comments Against CMS’ 2023 Outpatient Prospective Payment System
American Oncology Network (AON) commented against CMS' proposed CY 2023 Outpatient Prospective Payment System stating it will have grave effects on the sustainability of community oncology practices.
Fort Myers, Fla., August 18, 2022 – American Oncology Network, LLC (AON) expressed their concern regarding CMS' proposed CY 2023 Outpatient Prospective Payment System (OPPS) stating that it will undoubtedly cripple community health care practices.
While practices affiliated with health care systems and hospitals reap the benefits of the OPPS proposals, independent community practices were noted to have to reduce their payment rates to maintain neutrality and receive a decrease in Medicare payments. Moreover, increases in the 340B drug pricing to the average sale price plus 6% and the rise in Medicare reimbursement rates of 2.7% will further limit the ability of community practices to continue providing quality care, services, and medications to their patients.
“Community-based clinics provide high-quality care, services, and resources that are affordable and accessible,” said AON chief medical officer and Genesis Cancer and Blood Institute medical oncologist Stephen “Fred” Divers, MD. “These practices are critical players in closing the cancer care gap and driving health care equity. If they do not receive the support needed to continue providing care in their communities, our health care system has done a disservice to them and failed.”
Politics vs Science: The Future of US Public Health
February 4th 2025On this episode of Managed Care Cast, we speak with Perry N. Halkitis, PhD, MS, MPH, dean of the Rutgers School of Public Health, on the public health implications of the US withdrawal from the World Health Organization and the role of public health leaders in advocating for science and health.
Listen
Understanding Primary and Secondary Nonadherence to Chronic Oral Medication
March 28th 2025Medication nonadherence to oral anticoagulants and oral anti–prostate cancer medication has been scrutinized through new research conducted among patients and health care providers and presented by the American Medical Group Association at its 2025 annual meeting, held March 26-29 in Grapevine, Texas.
Read More
Texas Oncology to Roll Out Canopy for ePROs After Head-to-Head Pilot
March 18th 2025Debra Patt, MD, PhD, MBA, executive vice president of Public Policy and Strategy for Texas Oncology, said the practice received positive feedback from nurses and patients during a pilot that concluded in February.
Read More
